Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)

OBJECTIVES: To develop and validate the Osteoporosis Patient Satisfaction Questionnaire (OPSQ) and to assess the opinion of postmenopausal osteoporotic women towards pharmaceutical care. METHODS: A 16-item instrument was designed. Each response consists of a five-point Likert-like scale with higher...

Full description

Bibliographic Details
Main Authors: Lai, P.S., Chua, S.S., Chan, S.P., Low, W.Y., Wong, I.C.
Format: Article
Language:English
Published: 2010
Subjects:
Online Access:http://eprints.um.edu.my/9083/1/Lai-2010-Development_and_vali.pdf
_version_ 1796945858143453184
author Lai, P.S.
Chua, S.S.
Chan, S.P.
Low, W.Y.
Wong, I.C.
author_facet Lai, P.S.
Chua, S.S.
Chan, S.P.
Low, W.Y.
Wong, I.C.
author_sort Lai, P.S.
collection UM
description OBJECTIVES: To develop and validate the Osteoporosis Patient Satisfaction Questionnaire (OPSQ) and to assess the opinion of postmenopausal osteoporotic women towards pharmaceutical care. METHODS: A 16-item instrument was designed. Each response consists of a five-point Likert-like scale with higher scores indicating greater satisfaction. The face and content validity was established via consultation with an endocrinologist and three pharmacists as well as feedback from participants in a preliminary study. Postmenopausal osteoporotic women taking bisphosphonates were recruited and randomly allocated to the intervention (n=90) and control groups (n=90). Pharmaceutical care was provided at month 2 to the intervention group while the control group received standard pharmacy services. The OPSQ was administered at month 6 (end of the intervention period), to assess patients' satisfaction. Factor analysis was performed using varimax rotation. Internal reliability was established using Cronbach's alpha. Construct validity was performed by using the Mann-Whitney U test. RESULTS: The internal reliability of the OPSQ produced a Cronbach's alpha of 0.86. Factor analysis identified one component in the OPSQ, which measured patient satisfaction. The intervention group showed significantly better overall OPSQ score than the control group (91.89+/-7.22 versus 84.32+/-7.48, p<0.001). This indicates that the OPSQ was able to differentiate between participants who received pharmaceutical care from those who did not. CONCLUSIONS: The 16-item OPSQ developed in this study has high internal reliability and is a valid instrument for assessing osteoporotic women's satisfaction with pharmaceutical care service in Malaysia.
first_indexed 2024-03-06T05:22:53Z
format Article
id um.eprints-9083
institution Universiti Malaya
language English
last_indexed 2024-03-06T05:22:53Z
publishDate 2010
record_format dspace
spelling um.eprints-90832014-12-12T02:13:48Z http://eprints.um.edu.my/9083/ Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ) Lai, P.S. Chua, S.S. Chan, S.P. Low, W.Y. Wong, I.C. R Medicine OBJECTIVES: To develop and validate the Osteoporosis Patient Satisfaction Questionnaire (OPSQ) and to assess the opinion of postmenopausal osteoporotic women towards pharmaceutical care. METHODS: A 16-item instrument was designed. Each response consists of a five-point Likert-like scale with higher scores indicating greater satisfaction. The face and content validity was established via consultation with an endocrinologist and three pharmacists as well as feedback from participants in a preliminary study. Postmenopausal osteoporotic women taking bisphosphonates were recruited and randomly allocated to the intervention (n=90) and control groups (n=90). Pharmaceutical care was provided at month 2 to the intervention group while the control group received standard pharmacy services. The OPSQ was administered at month 6 (end of the intervention period), to assess patients' satisfaction. Factor analysis was performed using varimax rotation. Internal reliability was established using Cronbach's alpha. Construct validity was performed by using the Mann-Whitney U test. RESULTS: The internal reliability of the OPSQ produced a Cronbach's alpha of 0.86. Factor analysis identified one component in the OPSQ, which measured patient satisfaction. The intervention group showed significantly better overall OPSQ score than the control group (91.89+/-7.22 versus 84.32+/-7.48, p<0.001). This indicates that the OPSQ was able to differentiate between participants who received pharmaceutical care from those who did not. CONCLUSIONS: The 16-item OPSQ developed in this study has high internal reliability and is a valid instrument for assessing osteoporotic women's satisfaction with pharmaceutical care service in Malaysia. 2010 Article PeerReviewed application/pdf en http://eprints.um.edu.my/9083/1/Lai-2010-Development_and_vali.pdf Lai, P.S. and Chua, S.S. and Chan, S.P. and Low, W.Y. and Wong, I.C. (2010) Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ). Maturitas, 65 (1). pp. 55-63. ISSN 1873-4111,
spellingShingle R Medicine
Lai, P.S.
Chua, S.S.
Chan, S.P.
Low, W.Y.
Wong, I.C.
Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title_full Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title_fullStr Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title_full_unstemmed Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title_short Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ)
title_sort development and validation of the osteoporosis patient satisfaction questionnaire opsq
topic R Medicine
url http://eprints.um.edu.my/9083/1/Lai-2010-Development_and_vali.pdf
work_keys_str_mv AT laips developmentandvalidationoftheosteoporosispatientsatisfactionquestionnaireopsq
AT chuass developmentandvalidationoftheosteoporosispatientsatisfactionquestionnaireopsq
AT chansp developmentandvalidationoftheosteoporosispatientsatisfactionquestionnaireopsq
AT lowwy developmentandvalidationoftheosteoporosispatientsatisfactionquestionnaireopsq
AT wongic developmentandvalidationoftheosteoporosispatientsatisfactionquestionnaireopsq